Parkinson's disease managing reversible neurodegeneration [Corrigendum]
Hinz M, Stein A, Cole T, McDougall B, Westaway M. Neuropsychiatric Disease and Treatment. 2016;12:763–775.On page 774, Disclosure section, “MH discloses his relationship with DBS Laboratory services and NeuroResearch Clinics, Inc. The other authors report no conflicts of interest...
Guardado en:
| Autores principales: | , , , , |
|---|---|
| Formato: | article |
| Lenguaje: | EN |
| Publicado: |
Dove Medical Press
2016
|
| Materias: | |
| Acceso en línea: | https://doaj.org/article/efa130d8f10e493b89976379d6f63e5f |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
| id |
oai:doaj.org-article:efa130d8f10e493b89976379d6f63e5f |
|---|---|
| record_format |
dspace |
| spelling |
oai:doaj.org-article:efa130d8f10e493b89976379d6f63e5f2021-12-02T04:08:36ZParkinson's disease managing reversible neurodegeneration [Corrigendum]1178-2021https://doaj.org/article/efa130d8f10e493b89976379d6f63e5f2016-06-01T00:00:00Zhttps://www.dovepress.com/corrigendum-parkinsonrsquos-disease-managing-reversible-neuro-peer-reviewed-article-NDThttps://doaj.org/toc/1178-2021Hinz M, Stein A, Cole T, McDougall B, Westaway M. Neuropsychiatric Disease and Treatment. 2016;12:763–775.On page 774, Disclosure section, “MH discloses his relationship with DBS Laboratory services and NeuroResearch Clinics, Inc. The other authors report no conflicts of interest in this work” should have been “MH discloses his relationship with DBS Laboratory services and NeuroResearch Clinics, Inc. CHK Nutrition is a subsidiary of West Duluth Distribution Co. The CEO of this company is Amy M. Gunther-Hinz and the Registered Agent is Thais M Hinz. These persons are the daughter and the wife of Dr Marty Hinz. Thais Hinz is also a shareholder of West Duluth Distribution Co. The other authors report no conflicts of interest in this work”. Read the original articleHinz MStein ACole TMcDougall BWestaway MDove Medical PressarticleNeurosciences. Biological psychiatry. NeuropsychiatryRC321-571Neurology. Diseases of the nervous systemRC346-429ENNeuropsychiatric Disease and Treatment, Vol 2016, Iss Issue 1, Pp 1587-1588 (2016) |
| institution |
DOAJ |
| collection |
DOAJ |
| language |
EN |
| topic |
Neurosciences. Biological psychiatry. Neuropsychiatry RC321-571 Neurology. Diseases of the nervous system RC346-429 |
| spellingShingle |
Neurosciences. Biological psychiatry. Neuropsychiatry RC321-571 Neurology. Diseases of the nervous system RC346-429 Hinz M Stein A Cole T McDougall B Westaway M Parkinson's disease managing reversible neurodegeneration [Corrigendum] |
| description |
Hinz M, Stein A, Cole T, McDougall B, Westaway M. Neuropsychiatric Disease and Treatment. 2016;12:763–775.On page 774, Disclosure section, “MH discloses his relationship with DBS Laboratory services and NeuroResearch Clinics, Inc. The other authors report no conflicts of interest in this work” should have been “MH discloses his relationship with DBS Laboratory services and NeuroResearch Clinics, Inc. CHK Nutrition is a subsidiary of West Duluth Distribution Co. The CEO of this company is Amy M. Gunther-Hinz and the Registered Agent is Thais M Hinz. These persons are the daughter and the wife of Dr Marty Hinz. Thais Hinz is also a shareholder of West Duluth Distribution Co. The other authors report no conflicts of interest in this work”. Read the original article |
| format |
article |
| author |
Hinz M Stein A Cole T McDougall B Westaway M |
| author_facet |
Hinz M Stein A Cole T McDougall B Westaway M |
| author_sort |
Hinz M |
| title |
Parkinson's disease managing reversible neurodegeneration [Corrigendum] |
| title_short |
Parkinson's disease managing reversible neurodegeneration [Corrigendum] |
| title_full |
Parkinson's disease managing reversible neurodegeneration [Corrigendum] |
| title_fullStr |
Parkinson's disease managing reversible neurodegeneration [Corrigendum] |
| title_full_unstemmed |
Parkinson's disease managing reversible neurodegeneration [Corrigendum] |
| title_sort |
parkinson's disease managing reversible neurodegeneration [corrigendum] |
| publisher |
Dove Medical Press |
| publishDate |
2016 |
| url |
https://doaj.org/article/efa130d8f10e493b89976379d6f63e5f |
| work_keys_str_mv |
AT hinzm parkinson39sdiseasemanagingreversibleneurodegenerationcorrigendum AT steina parkinson39sdiseasemanagingreversibleneurodegenerationcorrigendum AT colet parkinson39sdiseasemanagingreversibleneurodegenerationcorrigendum AT mcdougallb parkinson39sdiseasemanagingreversibleneurodegenerationcorrigendum AT westawaym parkinson39sdiseasemanagingreversibleneurodegenerationcorrigendum |
| _version_ |
1718401465767165952 |